Hubalewska-Dydejczyk A, Decristoforo C, Mikolajczak R, Kolenc P, et al. Improving the Somatostatin Receptor Status Assessment for Personalized and Precise Management of Neuroendocrine Neoplasms with the Use of a (99m)Tc-Radiolabeled Somatostatin Receptor Antagonist: The Final Results of the ERA PerMed TECANT Clinical Tria J Nucl Med 2026;67:895-902.
PMID: 41887731